Abstract: Invention provides three new polymorphic from of Olanzapine for treatment of psychotic conditions. The new polymorphic forms of Olanzapine are designated as form III form IV and form V, which are conveniently prepared by dissolving Olanzapine in an aqueous organic or inorganic acid and precipitated using a suitable base. The Olanzapine can be obtained by varying the concentration of the acid, the temperature of precipitation and pH of the resultant mass after neutralization with alkali.
| # | Name | Date |
|---|---|---|
| 1 | 972-BOM-1999-CANCELLED PAGES.pdf | 2018-08-08 |
| 1 | 972-BOM-1999-SPECIFICATION(AMENDED).pdf | 2018-08-08 |
| 2 | 972-BOM-1999-CORRESPONDENCE(IPO).pdf | 2018-08-08 |
| 2 | 972-BOM-1999-FORMS.pdf | 2018-08-08 |
| 3 | 972-BOM-1999-CORRESPONDENCE(RECEIVED).pdf | 2018-08-08 |
| 3 | 972-BOM-1999-FORM 2(COMPLETE).pdf | 2018-08-08 |
| 4 | 972-BOM-1999-CORRESPONDENCE(RECEIVED).pdf | 2018-08-08 |
| 4 | 972-BOM-1999-FORM 2(COMPLETE).pdf | 2018-08-08 |
| 5 | 972-BOM-1999-CORRESPONDENCE(IPO).pdf | 2018-08-08 |
| 5 | 972-BOM-1999-FORMS.pdf | 2018-08-08 |
| 6 | 972-BOM-1999-CANCELLED PAGES.pdf | 2018-08-08 |
| 6 | 972-BOM-1999-SPECIFICATION(AMENDED).pdf | 2018-08-08 |